ZIM
CCCC icon

Zacks Investment Management’s C4 Therapeutics CCCC Stock Holding History

Zacks Investment Management’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,043
Closed -$29K – 748
2025
Q3 		$29K Buy
+13,043
New +$31.3K ﹤0.01% 737

Other funds holding CCCC

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

Zacks Investment Management's CCCC Position: Q4 2025 in Review

Zacks Investment Management sold out of C4 Therapeutics (CCCC) in Q4 2025, closing a stake of 13,043 shares — an estimated $29K sold.

Zacks Investment Management first reported a position in CCCC in Q3 2025 and held it in 1 quarter. The position peaked at $29K in Q3 2025. 101 funds tracked by Wall St. Rank hold CCCC as of Q4 2025.

  • Zacks Investment Management reported no remaining C4 Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Zacks Investment Management sold 13,043 C4 Therapeutics shares in Q4 2025, an estimated $29K.
  • Zacks Investment Management first reported a position in C4 Therapeutics in Q3 2025 and held it in 1 quarter.
  • Zacks Investment Management's C4 Therapeutics position peaked at $29K in Q3 2025.
  • 101 funds tracked by Wall St. Rank held C4 Therapeutics as of Q4 2025.

Based on Zacks Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.